featured
Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial
J. Clin. Oncol 2020 Aug 04;[EPub Ahead of Print], P DiSilvestro, N Colombo, G Scambia, BG Kim, A Oaknin, M Friedlander, A Lisyanskaya, A Floquet, A Leary, GS Sonke, C Gourley, S Banerjee, A Oza, A González-Martín, CA Aghajanian, WH Bradley, CA Mathews, J Liu, ES Lowe, R Bloomfield, KN MooreFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.